Xlear与Dr. Ferrer BioPharma合作,向用户提供更佳鼻腔卫生体验
犹他州亚美利加福克 (美国商业资讯)–Xlear今天宣布与Dr. Ferrer BioPharma (DFBP)建立新的伙伴关系,这将使Xlear鼻腔喷雾剂成为首款部署GentleMist喷嘴的鼻腔卫生工具。研究显示,这种新一代鼻腔喷雾剂技术的化合物弥散和覆盖更优、用户体验更佳。...
View Article新里程碑临床研究:后生元尿石素A (Mitopure™)可提高中年人肌肉力量和运动体能
瑞士洛桑和旧金山 (美国商业资讯)–Amazentis是瑞士联邦理工学院(EPFL)的衍生公司,引领细胞健康和营养领域的科学突破。该公司今天宣布,同行评议的临床和转化期刊《细胞报道医学》(Cell Reports Medicine)发表的新临床结果显示,肠道微生物组后生元尿石素A有益于肌肉健康。年龄相关的肌肉衰退最早可始于40岁,目前除运动之外缺乏有效的干预措施来延缓这种现象。...
View ArticleChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland...
LOS ANGELES ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced it has entered into an agreement (the “JV Agreement”) to establish a...
View ArticleSCAI 2022 Scientific Meetingで心原性ショックの予後改善に向けたImpellaの研究と進歩を大きく紹介
米マサチューセッツ州ダンバース (ビジネスワイヤ) — 画期的な心臓・肺・腎臓支援技術のリーダー企業であるアビオメッド(NASDAQ: ABMD)は、アトランタで5月19~22日に開催される米国心臓血管造影・インターベンション学会(SCAI)2022 Scientific...
View Article新たな画期的臨床試験によればポストバイオティクスのウロリチンA(マイトピュア)は中高年の筋力および運動能力を向上させる
スイス・ローザンヌ & サンフランシスコ (ビジネスワイヤ) — スイス連邦工科大学(EPFL)のスピンオフ企業で、細胞の健康と栄養における科学的ブレークスルーを先駆的に切り開いているアマゼンティスは、臨床・トランスレーショナル医学の査読誌Cell Reports...
View ArticleNew Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the American Journal of Emergency Medicine in which Dr. Gülsah Demir and colleagues at...
View Article訂正・差し替え SCAI 2022 Scientific Meeting で心原性ショックの予後改善に向けた Impella の研究と進歩を大きく紹介
米マサチューセッツ州ダンバース (ビジネスワイヤ) — 画期的な心臓・肺・腎臓支援技術のリーダー企業である アビオメッド(NASDAQ: ABMD)は、アトランタで5月19~22日に開催される米国心臓血管造影・インターベンション学会(SCAI)2022 Scientific...
View ArticleSermo调查显示,今年ASCO的与会肿瘤学家对新的肺癌和乳腺癌研究最感兴趣
纽约 医生优先的在线社区、全球医疗保健提供者(HCP)洞察领导者Sermo的一项新调查发现,在美国临床肿瘤学会(ASCO)年会期间,近一半(47%)的与会肿瘤学家对肺癌的新数据最感兴趣。紧随其后的是乳腺癌相关新数据,高达44%的受访肿瘤学家表示对此最感兴趣,此外,54%的肿瘤学家/血液学家表示最有兴趣了解肿瘤靶向抗体疗法。...
View Article中智全球寻求与台湾医疗保险公司结成战略联盟,为数百万台湾患者提供服务,确保他们能够远程获得可靠及优质的医疗保健服务。
达拉斯 (美国商业资讯)–中智全球(6819.HK)一直提供SEC³URE Ethos、SEC³URE Passport、Link & GO!、BioBytes™和BioBytes™...
View ArticleIntelliCentrics Seeks Strategic Alliance With Taiwanese Health Insurance...
DALLAS IntelliCentrics (6819.HK) connects trusted stakeholders across the continuum of care by delivering valuable, technology-enabled services such as the SEC³URE Ethos, SEC³URE Passport, Link...
View ArticleGenuv Announces Preclinical Data to be Released at Two Medical Conferences in...
SEOUL, South Korea Genuv Inc., a clinical-stage biotechnology company focused on innovative drug discovery for degenerative central nervous system diseases and advanced immuno-oncology therapeutics,...
View ArticlePharmaron Acquires Commercial API Manufacturing Facility in the United States
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered into a definitive Asset Purchase Agreement to acquire the Coventry API...
View Article新研究发现,Masimo PVi®或有助于急诊科医生确定哮喘患儿发作的严重程度
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天公布《美国急诊医学杂志》(American Journal of Emergency Medicine)发表的一项回顾性研究的结果。土耳其伊兹密尔Tepecik研究和培训医院的Gülsah Demir博士及其同事调查了Masimo...
View ArticleDr. Reddy’s Laboratories and Senores Pharmaceuticals, Inc. announce the...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) and...
View ArticleGlobal Aesthetics Brand Hugel Inc. Accelerates the Leap Forward as a Global...
NEWPORT BEACH, Calif. Hugel Inc., a global medical aesthetics company and South Korea’s leading company in the botulinum toxin and hyaluronic acid fillers market, announced to convene an...
View ArticleMasimo PVi®がER医による小児患者の喘息発作の重症度判定で役立ち得ることを示す新研究
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、American Journal of Emergency Medicine誌に掲載された後ろ向き研究の結果を発表しました。本試験では、トルコのイズミールにあるテペジキ研究研修病院のGülsah...
View ArticleIntelliCentrics’ Innovations Help Drive Advanced Dallas Hospital & Clinics’...
DALLAS IntelliCentrics (6819.HK) the innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™ and BioBytes™ Visitor, today announced Advanced Dallas Hospital & Clinics has...
View ArticleGenexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to...
SEOUL, South Korea Genexine (KOSDAQ: 095700) a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet...
View ArticleVeriSIM Life and Total Brain Announce Strategic Collaboration Agreement...
SAN FRANCISCO VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced that...
View Article